ISBP General Anxiety

ISBP General Anxiety

University

17 Qs

quiz-placeholder

Similar activities

Bingo Examination 2

Bingo Examination 2

University

20 Qs

CNS Stimulants 2

CNS Stimulants 2

University

14 Qs

Coopling Risk Management

Coopling Risk Management

6th Grade - Professional Development

19 Qs

NOCTI REVIEW 1

NOCTI REVIEW 1

9th Grade - University

14 Qs

PMHNP: Professional Role and Policies

PMHNP: Professional Role and Policies

12th Grade - University

22 Qs

Psychological Perspective

Psychological Perspective

University

15 Qs

Quiz #3

Quiz #3

University

12 Qs

RADS 1160 CN 6B Review Quiz

RADS 1160 CN 6B Review Quiz

University

17 Qs

ISBP General Anxiety

ISBP General Anxiety

Assessment

Quiz

Professional Development

University

Easy

Created by

Izzy Rios

Used 4+ times

FREE Resource

17 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Generalized Anxiety Disorder Assesment – 7 (GAD-7)

Clinitian rated

Self-Rated

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Generalized Anxiety Disorder Assesment – 7 (GAD-7)

further evaluation recommended when score is ____

greater or equal to 10

greater or equal to 15

5 or more

20 or more

3.

FILL IN THE BLANK QUESTION

1 min • 1 pt

General anxiety disorder

First line therapy

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

SSRI's can

be dosed once daily

not be dosed once daily

5.

FILL IN THE BLANK QUESTION

1 min • 1 pt

___________ (SNRI) is FDA approved for GAD (generalized anxiety disorder).

this SNRI has benefit for psychological symptoms (worry)

6.

FILL IN THE BLANK QUESTION

1 min • 1 pt

___________ (SNRI) is FDA approved for GAD (generalized anxiety disorder).

besides Venlafaxine there is the SNRI?

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Imipramine and trazodone are more effective than placebo, but are not first line due to poor tolerability and severe adverse reactions

True

False

Create a free account and access millions of resources

Create resources
Host any resource
Get auto-graded reports
or continue with
Microsoft
Apple
Others
By signing up, you agree to our Terms of Service & Privacy Policy
Already have an account?